• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-Q/A filed by PowerUp Acquisition Corp.

    10/24/24 5:18:37 PM ET
    $PWUP
    Blank Checks
    Finance
    Get the next $PWUP alert in real time by email
    true Q1 0001847345 --12-31 00-0000000 0001847345 2024-01-01 2024-03-31 0001847345 PWUP:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOnehalfOfOneRedeemableWarrantMember 2024-01-01 2024-03-31 0001847345 PWUP:ClassOrdinarySharesParValue0.0001PerShareIncludedAsPartOfUnitsMember 2024-01-01 2024-03-31 0001847345 PWUP:RedeemableWarrantsEachExercisableForOneClassOrdinaryShareFor11.50PerShareIncludedAsPartOfUnitsMember 2024-01-01 2024-03-31 0001847345 us-gaap:CommonClassAMember 2024-05-31 0001847345 us-gaap:CommonClassBMember 2024-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure PWUP:Integer

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q/A

    (Amendment No. 1)

     

    (Mark One)

     

    ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarterly period ended March 31, 2024

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from           to        

     

    Commission File No. 001-41293

     

    POWERUP ACQUISITION CORP.
    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   N/A

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

     

    188 Grand Street Unit #195

    New York, NY 10013

    (Address of Principal Executive Offices, including zip code)

     

    Tel: (347) 313-8109
    (Registrant’s telephone number, including area code)

     

    N/A
    (Former name, former address and former fiscal year, if changed since last report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one Redeemable Warrant   PWUPU   The Nasdaq Stock Market LLC
    Class A Ordinary Shares, par value $0.0001 per share, included as part of the Units   PWUP   The Nasdaq Stock Market LLC
    Redeemable Warrants each exercisable for one Class A Ordinary Share for $11.50 per share, included as part of the units   PWUPW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    ☐ Large accelerated filer ☐ Accelerated filer
    ☒ Non-accelerated filer ☒ Smaller reporting company
      ☒ Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐‌

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

     

    As of May 31, 2024 there were 7,765,144 Class A ordinary shares, par value $0.0001 per share, and 0 Class B ordinary shares, $0.0001 par value per share, issued and outstanding.

     

     

     

     

     

     

    Explanatory Note

     

    PowerUp Acquisition Corp. (the “Company,” “we”, or “our”) filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Original Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on June 5, 2024. The Company is now filing this Amendment No. 1 to the Original Form 10-Q (this “Form 10-Q/A”) solely for the purpose of amending and restating certifications by the Company’s principal executive officer and principal financial officer in Exhibits 31.1 and 31.2, respectively, of the Original Form 10-Q.

     

    In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Form 10-Q/A revises Item 15 of Part IV to include currently dated certifications by the Company’s principal executive officer and principal financial officer as exhibits to this Form 10-Q/A and updates the Exhibit Index to reflect the inclusion of these certifications as well as the amended and restated certifications included in Exhibits 31.1 and 31.2.

     

    Other than the items outlined above, this Form 10-Q/A does not attempt to modify or update the Original Form 10-Q. This Form 10-Q/A does not reflect events occurring after the date of the Original Form 10-Q or modify or update those disclosures that may be affected by subsequent events. Such subsequent matters are addressed in subsequent reports filed by the Company with the SEC. Accordingly, this Form 10-Q/A should be read in conjunction with the Original Form 10-Q. Capitalized terms not defined in this Form 10-Q/A have the meaning given to them in the Original Form 10-Q.

     

     

     

     

    POWERUP ACQUISITION CORP.

    FORM 10-Q/A FOR THE QUARTER ENDED MARCH 31, 2024

    TABLE OF CONTENTS

     

        Page
    PART II – OTHER INFORMATION 1
         
    Item 6. Exhibits 1
         
    SIGNATURES 2

     

    i
    Table of Contents

     

    PART II - OTHER INFORMATION

     

    ITEM 6. EXHIBITS

     

    The following exhibits are filed as part of, or incorporated by reference into, this Amendment No. 1 to Quarterly Report on Form 10-Q/A.

     

    Exhibit No.   Description
    10.1   Loan and Transfer Agreement, dated January 9, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, and Apogee Pharma Inc. (incorporated by reference from Exhibit 10.11 to the Form 10-K filed by PowerUp Acquisition Corp. on March 11, 2024).
    10.2   Amendment No. 1 to Secured Convertible Promissory Note, dated January 18, 2024, by and between Visiox Pharmaceuticals, Inc. and SRIRAMA Associates, LLC (incorporated by reference from Exhibit 10.13 to the Form S-4 filed by PowerUp Acquisition Corp. on January 26, 2024).
    10.3   Form of Subscription Agreement dated March 5, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, VKSS Capital, LLC, Visiox Pharmaceuticals, Inc., and Investor (incorporated by reference from Exhibit 10.12 to the Form 10-K filed by PowerUp Acquisition Corp. on March 11, 2024).
    10.4   Form of Subscription Agreement dated May 9, 2024, by and among PowerUp Acquisition Corp., SRIRAMA Associates, LLC, VKSS Capital, LLC, and Investor (incorporated by reference from Exhibit 10.16 to Amendment No. 1 to the Form S-4 filed by PowerUp Acquisition Corp. on May 14, 2024).
    10.5   Form of Non-Redemption Agreement (incorporated by reference from Exhibit 10.1 to the Form 8-K filed by PowerUp Acquisition Corp. on May 22, 2024).
    31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
    31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
    32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference from Exhibit 32.1 to the Form 10-Q filed by PowerUp Acquisition Corp. on June 5, 2024).
    32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (incorporated by reference from Exhibit 32.2 to the Form 10-Q filed by PowerUp Acquisition Corp. on June 5, 2024).
    101.INS*   Inline XBRL Instance Document
    101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
    101.SCH*   Inline XBRL Taxonomy Extension Schema Document
    101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
    101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
    101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
    104   Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101)

     

     

    *Filed herewith.

     

    1
    Table of Contents

     

    SIGNATURES

     

    In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      POWERUP ACQUISITION CORP.
         
    Date: October 24, 2024 By: /s/ Surendra Ajjarapu
      Name: Surendra Ajjarapu
      Title: Chief Executive Officer
        (Principal Executive Officer)
         
    Date: October 24, 2024 By: /s/ Howard Doss
      Name: Howard Doss
      Title: Chief Financial Officer
        (Principal Financial and Accounting Officer)

     

    2

     

     

    Get the next $PWUP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PWUP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PWUP
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by PowerUp Acquisition Corp.

    SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

    2/26/25 9:20:28 PM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell C

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/21/25 4:59:21 PM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/20/25 4:45:33 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Doshi Mayur Mansukhlal

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:32 PM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Wadhwani Avinash R

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:26 PM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form 3: New insider Ajjarapu Surendra K claimed ownership of 4,317,500 units of Class A Ordinary Shares

    3 - PowerUp Acquisition Corp. (0001847345) (Issuer)

    8/28/23 5:00:39 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

    Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing a pipeline of products utilizing its novel delivery mechanisms to enhance the efficacy of "do no harm" FDA approved drugs, nutraceuticals and supplements.Innovative Drug Delivery Technology: Aspire's patented and patent-pending delivery system includes components specifically formulated to allow rapid sublingual absorption of drugs directly into the blood stream, thus on first pass, avoiding the gastrointestinal tract and liver, mitigating unwanted toxicity of this critical organ.Growth and

    9/3/24 8:01:00 AM ET
    $PWUP
    Blank Checks
    Finance

    Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

    Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (NASDAQ:PWUP), a Nasdaq Global Market® listed special purpose acquisition company ("PowerUp"), today announced that they have signed a non-binding letter of intent ("LOI") for a potential business combination ("Business Combination"). Under the terms of the LOI, following the consummation of the Business Combination, the combined public company would be listed on a national securities exchange. Aspire Biopharma, Inc. is a privately held, early-stag

    7/31/24 8:01:00 AM ET
    $PWUP
    Blank Checks
    Finance

    PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that, on June 3, 2024, the Company received a notice (the "Notice") from the Nasdaq Listing Qualifications Department ("Nasdaq") indicating that the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission ("SEC"). The Notice indicates that the Company must, no later than August 2, 2024, submit a plan to regain compliance with respect to the filing requirement. Followi

    6/5/24 4:05:00 PM ET
    $PWUP
    Blank Checks
    Finance

    $PWUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PowerUp Acquisition Corp.

    SC 13G/A - PowerUp Acquisition Corp. (0001847345) (Subject)

    7/30/24 10:56:11 AM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form SC 13G filed by PowerUp Acquisition Corp.

    SC 13G - PowerUp Acquisition Corp. (0001847345) (Subject)

    5/28/24 7:58:56 AM ET
    $PWUP
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by PowerUp Acquisition Corp. (Amendment)

    SC 13G/A - PowerUp Acquisition Corp. (0001847345) (Subject)

    2/14/24 9:33:46 AM ET
    $PWUP
    Blank Checks
    Finance